Tom Kindlon on Nostr: A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong: a ...

A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong: a randomised, double-blind, placebo-controlled trial

https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00685-0/fulltext

Always interesting to see results of trials like this that provide much better evidence than open label studies

npub18fz872n76uamwc0kkvft8efrxe0zj4xmxqqe6xc55pe9gm6p2s0q9rhy22 (npub18fz…hy22)
#LongCovid #PwLC #PostCovidSyndrome #LC #PASC #postcovid npub1ua6wgn0vpjmh4ep4alvvj0z3hws4ap5yd3txyp6h04xn7atjh4qq25gx9n (npub1ua6…gx9n)
#COVIDー19 #COVID19 #COVID #COVID_19 #SARSCoV2 #CovidBrain

1/